Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$500M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$470M |
| 3 |
Fortis
FTS
|
+$409M |
| 4 |
AABA
Altaba Inc
AABA
|
+$378M |
| 5 |
Booking.com
BKNG
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.9B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$828M |
| 3 |
Tesla
TSLA
|
+$716M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$585M |
| 5 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$539M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.92% |
| 2 | Financials | 9.63% |
| 3 | Healthcare | 8.27% |
| 4 | Consumer Discretionary | 7.53% |
| 5 | Communication Services | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Acadia Pharmaceuticals
ACAD
$4.65B
| $6.05M | ﹤0.01% |
216,959
+27,712
| +15% | +$826K |
|
|
RMT
2602
Royce Micro-Cap Trust
RMT
$760M
| $6.04M | ﹤0.01% |
698,793
-45,831
| -6% | -$393K |
|
|
KTF
2603
DWS Municipal Income Trust
KTF
$350M
| $6.04M | ﹤0.01% |
447,657
+17,251
| +4% | +$233K |
|
|
RPXC
2604
DELISTED
RPX Corporation
RPXC
| $6.04M | ﹤0.01% |
432,614
-25,254
| -6% | -$336K |
|
2605
Invesco Global Water ETF
PIO
$283M
| $6.02M | ﹤0.01% |
253,863
+10,801
| +4% | +$254K |
|
|
IBDO
2606
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| $6.02M | ﹤0.01% |
238,896
+30,958
| +15% | +$779K |
|
2607
First Hawaiian
FHB
$3.44B
| $6.01M | ﹤0.01% |
196,305
-87,631
| -31% | -$2.56M |
|
|
KYNB
2608
Kyntra Bio
KYNB
$28M
| $6.01M | ﹤0.01% |
7,440
+861
| +13% | +$600K |
|
2609
Sarepta Therapeutics
SRPT
$1.73B
| $6.01M | ﹤0.01% |
178,184
-11,926
| -6% | -$388K |
|
|
TRTN
2610
DELISTED
Triton International Limited
TRTN
| $6M | ﹤0.01% |
179,541
+20,644
| +13% | +$610K |
|
2611
National Health Investors
NHI
$3.61B
| $6M | ﹤0.01% |
75,715
-27,278
| -26% | -$2.06M |
|
|
CSF
2612
DELISTED
VictoryShares US Discovery Enhanced Volatility Wtd ETF
CSF
| $6M | ﹤0.01% |
144,689
+84,625
| +141% | +$3.46M |
|
2613
Integer Holdings
ITGR
$4.25B
| $5.99M | ﹤0.01% |
138,544
+26,460
| +24% | +$1.05M |
|
2614
Oaktree Specialty Lending
OCSL
$1.07B
| $5.98M | ﹤0.01% |
410,449
-102,827
| -20% | -$1.31M |
|
2615
iShares MSCI USA Equal Weighted ETF
EUSA
$1.88B
| $5.98M | ﹤0.01% |
117,383
+14,805
| +14% | +$746K |
|
2616
Ezcorp Inc
EZPW
$1.91B
| $5.98M | ﹤0.01% |
777,022
-199,769
| -20% | -$1.74M |
|
2617
Fidelity MSCI Financials Index ETF
FNCL
$2.42B
| $5.97M | ﹤0.01% |
164,250
+25,234
| +18% | +$886K |
|
2618
Cato Corp
CATO
$66.5M
| $5.95M | ﹤0.01% |
338,046
+68,380
| +25% | +$1.4M |
|
2619
State Street SPDR S&P Capital Markets ETF
KCE
$472M
| $5.94M | ﹤0.01% |
120,731
+1,877
| +2% | +$88.4K |
|
2620
Invesco S&P MidCap 400 Pure Value ETF
RFV
$341M
| $5.94M | ﹤0.01% |
94,059
-1,677
| -2% | -$104K |
|
2621
Churchill Downs
CHDN
$5.95B
| $5.93M | ﹤0.01% |
194,196
-100,578
| -34% | -$2.85M |
|
2622
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
| $5.93M | ﹤0.01% |
53,563
+4,269
| +9% | +$473K |
|
2623
Stratasys
SSYS
$764M
| $5.92M | ﹤0.01% |
254,088
+6,527
| +3% | +$168K |
|
|
TDF
2624
Templeton Dragon Fund
TDF
$274M
| $5.92M | ﹤0.01% |
293,505
-22,377
| -7% | -$433K |
|
2625
Spok Holdings
SPOK
$234M
| $5.92M | ﹤0.01% |
334,248
+44,925
| +16% | +$804K |
|
Similar funds
Morgan Stanley's Q2 2017 Portfolio in Review
As of Q2 2017, Morgan Stanley held 6,874 positions worth $331B, up 1.7% from $325B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q2 2017 filing shows 204 new, 2,959 increased, 3,018 reduced and 165 closed positions. Its largest new stake was Altaba Inc: 6,949,032 shares worth $379M. The largest sale was iShares Russell 2000 ETF, an estimated $1.9B.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, up from 9.4% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q2 2017 buy was Altaba Inc: 6,949,032 shares worth $379M.
- Morgan Stanley added most to Starbucks in Q2 2017, an estimated $500M increase.
- Morgan Stanley's biggest Q2 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.9B.
- Morgan Stanley fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $539M.
- Morgan Stanley's ten largest holdings make up 12% of its $331B portfolio in Q2 2017.
- Morgan Stanley opened 204 new positions and closed 165 in Q2 2017.
- Morgan Stanley's portfolio value rose 1.7% quarter-over-quarter to $331B.
Based on Morgan Stanley's 13F filing for Q2 2017, filed 11 Aug 2017.